Abstract:Objective To investigate the clinical effect and adverse reactions of three vasoactive drugs,Octreotide,Somatostatin and Pituitrin in the treatment of esophageal and gastric variceal bleeding caused by cirrhosis,and to analyze the economy of different drug treatment regimen.Methods From July 2017 to December 2019,according to the three vasoactive drugs (Octreotide,Somatostatin and Pituitrin) 20 patients with esophageal and gastric variceal bleeding caused by cirrhosis treated in Lingyuan Central Hospital,Liaoning Province were selected respectively.The three vasoactive drugs corresponded to three different medication methods and different medication.The clinical effect,adverse reactions and drug economy of different drug use methods were compared and analyzed comprehensively.Results The total effective rates of clinical treatment in Somatostatin group and Octreotide group were higher than those in Pituitrin group,the differences were statistically significant (P<0.05);during the treatment period,no significant adverse reactions were found in Somatostatin group and Octreotide group,while in Pituitrin group,abdominal pain and increased stool frequency were found in 7 patients,and 1 patient was intolerable due to pain during the treatment period,1 patient was found nausea and vomiting,1 patient was found dizziness,headaches.The drug costs of Somatostatin group and Octreotide group were higher than those of Pituitrin group,the differences were statistically significant (P<0.05).Conclusion Octreotide and Somatostatin have better clinical effect and lower adverse reactions than Pituitrin in the clinical treatment of patients with esophageal and gastric variceal bleeding caused by cirrhosis,but Pituitrin has price advantage.It is suggested that the clinical treatment plan should be considered comprehensively according to the actual situation of patients.
席艳. 三种血管活性药物治疗肝硬化致食管胃底静脉曲张破裂出血的临床效果[J]. 中国当代医药, 2021, 28(1): 53-55.
XI Yan. Clinical effect of three vasoactive drugs in the treatment of esophageal variceal bleeding caused by cirrhosis. 中国当代医药, 2021, 28(1): 53-55.